 <h1>Triglide Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>fenofibrate</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about fenofibrate. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Triglide.</p><h2>In Summary</h2><p><b>Common side effects of Triglide include:</b> increased serum aspartate aminotransferase and increased serum alanine aminotransferase. <b>Other side effects include:</b> abnormal hepatic function tests, increased creatine phosphokinase in blood specimen, and increased serum transaminases.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to fenofibrate: oral capsule, oral tablet</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, fenofibrate (the active ingredient contained in Triglide) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking fenofibrate:</p><p>
<i>Less common</i>
</p><ul>
<li>Chills</li>
<li>fever</li>
<li>hives, itching, or skin rash</li>
<li>muscle aches and pains</li>
<li>nausea</li>
<li>stomach pain</li>
<li> vomiting</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Chronic indigestion</li>
<li>dark urine</li>
<li>muscle cramps, spasms, stiffness, swelling, or weakness</li>
<li>troubled breathing</li>
<li>unusual bleeding or bruising</li>
<li>unusual tiredness or weakness</li>
<li>yellow eyes or skin</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Agitation</li>
<li>bloating</li>
<li>bloody urine</li>
<li>constipation</li>
<li>decreased frequency or amount of urine</li>
<li>difficulty in moving</li>
<li>fast heartbeat</li>
<li>general tiredness and weakness</li>
<li>increased blood pressure</li>
<li>increased thirst</li>
<li>indigestion</li>
<li>joint pain or swelling</li>
<li>light-colored stools</li>
<li>loss of appetite</li>
<li>lower back or side pain</li>
<li>pains in the stomach, side, or abdomen, possibly radiating to the back</li>
<li>pale skin</li>
<li>swelling of the face, fingers, or lower legs</li>
<li>troubled breathing with exertion</li>
<li>upper right abdominal or stomach pain</li>
<li>weight gain</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of fenofibrate may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Runny nose</li>
<li>sneezing</li>
<li>stuffy nose</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Back pain</li>
<li>diarrhea</li>
<li>eye irritation</li>
<li>gas</li>
<li>increased sensitivity of the skin to sunlight</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Lack or loss of strength</li>
</ul><p>
<!-- end oral capsule, oral tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to fenofibrate: oral capsule, oral tablet</i></p><h3>General</h3><p>The most frequently reported side effects have included abnormal liver tests, increased transaminases (ALT and AST), increased creatine phosphokinase (CPK), and rhinitis.<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): Liver function tests abnormal, AST increased, ALT increased</p>
<p><b>Uncommon</b> (0.1% to 1%): Cholelithiasis</p>
<p><b>Rare</b> (less than 0.1%): Hepatitis</p>
<p><b>Postmarketing reports</b>: Cirrhosis, liver fatty deposit, cholecystitis, jaundice, cholangitis, biliary colic<sup>[Ref]</sup></p><p>During clinical trials, transaminase increases to greater than 3 times the upper limit of normal (3 x ULN) occurred in 5.3% of patients taking fenofibrate compared with 1.1% of those on placebo; the incidence of increased transaminases appeared to be dose-related.<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Rhinitis (up to 23.2%), bronchitis (16.4%)</p>
<p><b>Common</b> (1% to 10%): Respiratory disorder, pharyngitis, sinusitis</p>
<p><b>Uncommon</b> (0.1% to 1%): Pulmonary embolism</p>
<p><b>Very rare</b> (less than 0.01%): Interstitial pneumopathy</p>
<p><b>Frequency not reported</b>: Cough increased, dyspnea, asthma, pneumonia, laryngitis</p>
<p><b>Postmarketing reports</b>: Interstitial lung disease<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Arthralgia (up to 25.1%), back pain (up to 15%)</p>
<p><b>Common</b> (1% to 10%): Back pain, myalgia</p>
<p><b>Uncommon</b> (0.1% to 1%): Diffuse myalgia, myositis, muscle cramp, muscle weakness</p>
<p><b>Very rare</b> (less than 0.01%): Rhabdomyolysis</p>
<p><b>Frequency not reported</b>: Arthritis, tenosynovitis, joint disorder, arthrosis, leg cramp, bursitis, myasthenia</p>
<p><b>Postmarketing reports</b>: Muscle spasm<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Abdominal pain (up to 15.9%)</p>
<p><b>Common</b> (1% to 10%): Nausea, constipation, diarrhea, vomiting, flatulence</p>
<p><b>Uncommon</b> (0.1% to 1%): Pancreatitis</p>
<p><b>Frequency not reported</b>: Dyspepsia, gastroenteritis, rectal disorder, esophagitis, gastritis, colitis, tooth disorder, gastrointestinal disorder, duodenal ulcer, peptic ulcer, rectal hemorrhage, eructation, gamma glutamyl transpeptidase, dry mouth<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache, dizziness</p>
<p><b>Rare</b> (less than 0.1%): Peripheral neuropathy</p>
<p><b>Frequency not reported</b>: Migraine, paresthesia, hypertonia, neuralgia, somnolence<sup>[Ref]</sup></p><h3>Dermatologic</h3><p>Photosensitivity reactions have been reported days to months after initiation; in some cases, a prior photosensitivity reaction to ketoprofen had been reported.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Rash, pruritus, urticaria</p>
<p><b>Uncommon</b> (0.1% to 1%): Photosensitivity reaction</p>
<p><b>Rare</b> (0.01% to 0.1%): Alopecia</p>
<p><b>Very rare</b> (less than 0.01%): Cutaneous photosensitivity with erythema, vesiculation, nodulation</p>
<p><b>Frequency not reported</b>: Erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, eczema, acne, sweating, fungal dermatitis, skin disorder, contact dermatitis, maculopapular rash, nail disorder, skin ulcer</p>
<p><b>Postmarketing reports</b>: Ecchymosis<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Uncommon</b> (0.1% to 1%): Deep vein thrombosis</p>
<p><b>Frequency not reported</b>: Angina pectoris, hypertension, vasodilatation, coronary artery disorder, electrocardiogram abnormal, extrasystole, myocardial infarct, peripheral vascular disorder, varicose vein, cardiovascular disorder, hypotension, palpitation, arrhythmia, phlebitis, tachycardia, atrial fibrillation<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Conjunctivitis</p>
<p><b>Frequency not reported</b>: Eye disorder, amblyopia, abnormal vision, cataract specified, refraction disorder<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Accidental injury (up to 18.4%), flu syndrome (up to 17.9%), chest pain (up to 10.1%)</p>
<p><b>Common</b> (1% to 10%): Creatine phosphokinase increased, malaise, vertigo, fatigue</p>
<p><b>Uncommon</b> (0.1% to 1%): Serum creatinine increased, urea increased</p>
<p><b>Rare</b> (less than 0.1%): Sexual asthenia</p>
<p><b>Frequency not reported</b>: Pain, infection, cyst, hernia, fever, peripheral edema, ear pain, otitis media, herpes zoster, herpes simplex, weight gain, weight loss, edema</p>
<p><b>Postmarketing reports</b>: Asthenia<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Uncommon</b> (0.1% to 1%): Sexual dysfunction</p>
<p><b>Frequency not reported</b>: Urinary frequency, prostatic disorder, dysuria, gynecomastia, vaginal moniliasis, cystitis<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Rare</b> (less than 0.1%): Hemoglobin decreased, leukopenia</p>
<p><b>Frequency not reported</b>: Eosinophilia, lymphadenopathy, thrombocytopenia, anemia</p>
<p><b>Postmarketing reports</b>: Hematocrit decreased<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Frequency not reported</b>: Appetite increased, anorexia, diabetes mellitus, hypoglycemia, gout, hyperuricemia</p>
<p><b>Postmarketing reports</b>: High-density lipoprotein cholesterol levels severely depressed<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Frequency not reported</b>: Kidney function abnormal, urolithiasis</p>
<p><b>Postmarketing reports</b>: Renal failure, acute renal failure<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Insomnia</p>
<p><b>Frequency not reported</b>: Depression, libido decreased, anxiety, nervousness<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Frequency not reported</b>: Diabetes mellitus<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Rare</b> (less than 0.1%): Hypersensitivity reaction</p>
<p><b>Frequency not reported</b>: Allergic reaction<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. "Product Information. Tricor (fenofibrate)." Abbott Pharmaceutical, Abbott Park, IL. </p><p id="ref_4">4. "Product Information. Lofibra (fenofibrate)." Teva Pharmaceuticals (formerly Gate Pharmaceuticals), Sellersville, PA. </p><p id="ref_5">5. "Product Information. Fenoglide (fenofibrate)." Santarus Inc, San Diego, CA. </p><p id="ref_6">6. "Product Information. Fenofibrate (fenofibrate)." Mylan Pharmaceuticals Inc, Morgantown, WV. </p><p id="ref_7">7. "Product Information. Triglide (fenofibrate)." Sciele Pharma Inc, Atlanta, GA. </p><p id="ref_8">8. "Product Information. Antara (fenofibrate)." Lupin Pharmaceuticals Inc, Baltimore, MD. </p><p id="ref_9">9. "Product Information. Lipofen (fenofibrate)." Kowa Pharmaceuticals America (formerly ProEthic), Montgomery, AL. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about Triglide (fenofibrate)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>En Español</li>
<li>Drug class: fibric acid derivatives</li>
<li>FDA Approval History</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Triglide &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>TriCor, Lofibra, Antara, Lipofen, Fenoglide</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Hyperlipoproteinemia</li>
<li>Hyperlipoproteinemia Type IIa, Elevated LDL</li>
<li>Hyperlipoproteinemia Type IIb, Elevated LDL   VLDL</li>
<li>Hyperlipoproteinemia Type IV, Elevated VLDL</li>
<li>Hyperlipoproteinemia Type V, Elevated Chylomicrons   VLDL</li>
<li>Hypertriglyceridemia</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to fenofibrate: oral capsule, oral tablet</i></p><h3>General</h3><p>The most frequently reported side effects have included abnormal liver tests, increased transaminases (ALT and AST), increased creatine phosphokinase (CPK), and rhinitis.<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): Liver function tests abnormal, AST increased, ALT increased</p><p><b>Uncommon</b> (0.1% to 1%): Cholelithiasis</p><p><b>Rare</b> (less than 0.1%): Hepatitis</p><p><b>Postmarketing reports</b>: Cirrhosis, liver fatty deposit, cholecystitis, jaundice, cholangitis, biliary colic<sup>[Ref]</sup></p><p>During clinical trials, transaminase increases to greater than 3 times the upper limit of normal (3 x ULN) occurred in 5.3% of patients taking fenofibrate compared with 1.1% of those on placebo; the incidence of increased transaminases appeared to be dose-related.<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Rhinitis (up to 23.2%), bronchitis (16.4%)</p><p><b>Common</b> (1% to 10%): Respiratory disorder, pharyngitis, sinusitis</p><p><b>Uncommon</b> (0.1% to 1%): Pulmonary embolism</p><p><b>Very rare</b> (less than 0.01%): Interstitial pneumopathy</p><p><b>Frequency not reported</b>: Cough increased, dyspnea, asthma, pneumonia, laryngitis</p><p><b>Postmarketing reports</b>: Interstitial lung disease<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Arthralgia (up to 25.1%), back pain (up to 15%)</p><p><b>Common</b> (1% to 10%): Back pain, myalgia</p><p><b>Uncommon</b> (0.1% to 1%): Diffuse myalgia, myositis, muscle cramp, muscle weakness</p><p><b>Very rare</b> (less than 0.01%): Rhabdomyolysis</p><p><b>Frequency not reported</b>: Arthritis, tenosynovitis, joint disorder, arthrosis, leg cramp, bursitis, myasthenia</p><p><b>Postmarketing reports</b>: Muscle spasm<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Abdominal pain (up to 15.9%)</p><p><b>Common</b> (1% to 10%): Nausea, constipation, diarrhea, vomiting, flatulence</p><p><b>Uncommon</b> (0.1% to 1%): Pancreatitis</p><p><b>Frequency not reported</b>: Dyspepsia, gastroenteritis, rectal disorder, esophagitis, gastritis, colitis, tooth disorder, gastrointestinal disorder, duodenal ulcer, peptic ulcer, rectal hemorrhage, eructation, gamma glutamyl transpeptidase, dry mouth<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache, dizziness</p><p><b>Rare</b> (less than 0.1%): Peripheral neuropathy</p><p><b>Frequency not reported</b>: Migraine, paresthesia, hypertonia, neuralgia, somnolence<sup>[Ref]</sup></p><h3>Dermatologic</h3><p>Photosensitivity reactions have been reported days to months after initiation; in some cases, a prior photosensitivity reaction to ketoprofen had been reported.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Rash, pruritus, urticaria</p><p><b>Uncommon</b> (0.1% to 1%): Photosensitivity reaction</p><p><b>Rare</b> (0.01% to 0.1%): Alopecia</p><p><b>Very rare</b> (less than 0.01%): Cutaneous photosensitivity with erythema, vesiculation, nodulation</p><p><b>Frequency not reported</b>: Erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, eczema, acne, sweating, fungal dermatitis, skin disorder, contact dermatitis, maculopapular rash, nail disorder, skin ulcer</p><p><b>Postmarketing reports</b>: Ecchymosis<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Uncommon</b> (0.1% to 1%): Deep vein thrombosis</p><p><b>Frequency not reported</b>: Angina pectoris, hypertension, vasodilatation, coronary artery disorder, electrocardiogram abnormal, extrasystole, myocardial infarct, peripheral vascular disorder, varicose vein, cardiovascular disorder, hypotension, palpitation, arrhythmia, phlebitis, tachycardia, atrial fibrillation<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Conjunctivitis</p><p><b>Frequency not reported</b>: Eye disorder, amblyopia, abnormal vision, cataract specified, refraction disorder<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Accidental injury (up to 18.4%), flu syndrome (up to 17.9%), chest pain (up to 10.1%)</p><p><b>Common</b> (1% to 10%): Creatine phosphokinase increased, malaise, vertigo, fatigue</p><p><b>Uncommon</b> (0.1% to 1%): Serum creatinine increased, urea increased</p><p><b>Rare</b> (less than 0.1%): Sexual asthenia</p><p><b>Frequency not reported</b>: Pain, infection, cyst, hernia, fever, peripheral edema, ear pain, otitis media, herpes zoster, herpes simplex, weight gain, weight loss, edema</p><p><b>Postmarketing reports</b>: Asthenia<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Uncommon</b> (0.1% to 1%): Sexual dysfunction</p><p><b>Frequency not reported</b>: Urinary frequency, prostatic disorder, dysuria, gynecomastia, vaginal moniliasis, cystitis<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Rare</b> (less than 0.1%): Hemoglobin decreased, leukopenia</p><p><b>Frequency not reported</b>: Eosinophilia, lymphadenopathy, thrombocytopenia, anemia</p><p><b>Postmarketing reports</b>: Hematocrit decreased<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Frequency not reported</b>: Appetite increased, anorexia, diabetes mellitus, hypoglycemia, gout, hyperuricemia</p><p><b>Postmarketing reports</b>: High-density lipoprotein cholesterol levels severely depressed<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Frequency not reported</b>: Kidney function abnormal, urolithiasis</p><p><b>Postmarketing reports</b>: Renal failure, acute renal failure<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Insomnia</p><p><b>Frequency not reported</b>: Depression, libido decreased, anxiety, nervousness<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Frequency not reported</b>: Diabetes mellitus<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Rare</b> (less than 0.1%): Hypersensitivity reaction</p><p><b>Frequency not reported</b>: Allergic reaction<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. "Product Information. Tricor (fenofibrate)." Abbott Pharmaceutical, Abbott Park, IL. </p><p id="ref_4">4. "Product Information. Lofibra (fenofibrate)." Teva Pharmaceuticals (formerly Gate Pharmaceuticals), Sellersville, PA. </p><p id="ref_5">5. "Product Information. Fenoglide (fenofibrate)." Santarus Inc, San Diego, CA. </p><p id="ref_6">6. "Product Information. Fenofibrate (fenofibrate)." Mylan Pharmaceuticals Inc, Morgantown, WV. </p><p id="ref_7">7. "Product Information. Triglide (fenofibrate)." Sciele Pharma Inc, Atlanta, GA. </p><p id="ref_8">8. "Product Information. Antara (fenofibrate)." Lupin Pharmaceuticals Inc, Baltimore, MD. </p><p id="ref_9">9. "Product Information. Lipofen (fenofibrate)." Kowa Pharmaceuticals America (formerly ProEthic), Montgomery, AL. </p><h2>More about Triglide (fenofibrate)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>En Español</li>
<li>Drug class: fibric acid derivatives</li>
<li>FDA Approval History</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Triglide &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Hyperlipoproteinemia</li>
<li>Hyperlipoproteinemia Type IIa, Elevated LDL</li>
<li>Hyperlipoproteinemia Type IIb, Elevated LDL   VLDL</li>
<li>Hyperlipoproteinemia Type IV, Elevated VLDL</li>
<li>Hyperlipoproteinemia Type V, Elevated Chylomicrons   VLDL</li>
<li>Hypertriglyceridemia</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>